Dr. Michele Carbone discusses the genetics of mesothelioma, and his research in this area, particularly as it relates to the BAP-1 gene. This interview is…
1717 K Street NW, Suite 900
Washington, DC 20006-5349
(877) 363-6376
HELPLINE
Garrett Nash, MD, discusses peritoneal and benign presentations of mesothelioma and their respective treatment. Dr. Nash is a surgical oncologist at Memorial Sloan Kettering Cancer…
Moderated by Daniel Sterman, MD, this panel of mesothelioma patients who underwent an EPP (extrapleural pneumonectomy — lung removal) discuss their experience and side-effects prior…
This “Fundraising for the Foundation” panel discusses their Fundraise for Meso events, best practices, and answered questions from moderator Katie Jamieson, co-chair of the Community…
Andreas Rimner, MD discusses a phase 3 clinical trial that is testing the addition of IMRT (intensity-modulated radiotherapy) to pemetrexed (Alimta)/platinum based therapy for pleural…
Sean Drake, MD provides an overview of vaccinations — tetanus, diphtheria and pertussis, hepatitis A, hepatitis B, pneumonia, pneumovax, prevnar 13, shingles, shingrix, influenza (flu),…
Arkadiusz Dudek, MD, PhD, discusses the Phase 2 Nivolumab (Opdivo) + Ramucirumab clinical trial for previously-treated mesothelioma patients. The study is available at Moffitt Cancer…
Dr. Paul Sugarbaker joins us for an interview about HIPEC (hyperthermic intraperitoneal chemotherapy) for peritoneal mesothelioma. Paul Sugarbaker, MD, FACS, FRCS, is the Chief of…
Three mesothelioma patients shared their experiences with cancer-related cognitive impairment — also known as “chemo brain” — with Dr. Tracy Vannorsdall, a neuropsychologist at the…
For MesoTV, we brought back a valuable conversation about complementary vs alternative therapies from a previous conference on malignant mesothelioma in New York City. In…